-
New Approach Announced for Processing Complaints to the FDA
The U.S. Food and Drug Administration (FDA) announced a major improvement in its system for processing complaints today.…
-
FDA Announces Recalls for Plastic Syringes Made in China
The FDA has announced added recalls initiated by Medline Industries, LP concerning plastic syringes manufactured in China. The…
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
On March 8, 2024, The U.S. FDA has approved Wegovy (semaglutide) injection, a weight management medication also designed…
-
First Over-the-Counter Glucose Monitor Gets Clearance From the FDA
The U.S. Food and Drug Administration (FDA) has granted marketing clearance to the first over-the-counter continuous glucose monitor…
-
CDC Released Updated Recommendations for Respiratory Virus
On March 1, 2024, the Center for Disease Control and Prevention (CDC) released updated guidelines for combatting respiratory…
-
First Transcatheter Therapy for Tricuspid Valve Replacement Gains FDA Approval
On February 1, Edwards EVOQUE Tricuspid Valve Replacement System was approved by the FDA. The system treats patients…
-
Janus Kinase Inhibitor Treatment Approved for Severe Alopecia Areata
Alopecia is a devastating tissue-specific autoimmune condition caused by the T-cell-mediated destruction of hair follicles. This leads to…
-
New Therapy for Sickle Cell Disease
Sickle cell disease (SCD) is an inherited genetic mutation causing normally round or disc-shaped cells to develop as…
-
FDA Deems Phenylephrine ‘Ineffective’
Phenylephrine, the mainstay in many OTC nasal decongestant preparations such as Dayquil and Sudafed, and some nasal sprays,…
-
FDA Reevaluates Over-the-Counter Cold Medications
Phenylephrine, a key ingredient in many over-the-counter cold preparations, has been re-evaluated by the FDA Advisory panel who…
-
Hyperlipidemia treatments gaining popularity
Two newer FDA-approved treatments for hyperlipidemia are gaining popularity due to their effectiveness and dosing. A statin alternative,…
-
New Oral Medication to Treat Postpartum Depression Approved by FDA
Between 6.5% and 20% of new mothers develop postpartum depression (PPD), though many more may go undiagnosed. PPD…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
-
FDA Releases Updated Women’s Health Research Roadmap
-
Counterfeit Prescriptions from Online Pharmacies Are Posing a Health Risk
-
Compounding Group Sues FDA for Removing Weight-Loss Medications from Short-Supply List
-
New Approach Announced for Processing Complaints to the FDA
-
When, Why, and How to Prescribe During Cold and Flu Season
-
Tips for Landing Your First Nurse Practitioner Job
-
How Teamwork Can Help Prevent Malpractice Incidents for Nurse Practitioners
-
Sharpen Your Sherlock Skills: Mastering the Art of the Differential Diagnosis
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.